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Abstract We present here two cases of incidental ex-
tranodal marginal zone B-cell lymphoma of mucosa-
associated lymphoid tissue (MALT lymphoma) showing
prominent plasma cell differentiation associated with Ha-
shimoto’s thyroiditis (HT). Histological examination
demonstrated that both lesions exhibited HT including
lymphoplasmacytic inﬁltration with the formation of ger-
minal centers, destruction of the normal thyroid follicular
architecture, Hu ¨rthle cell changes, and squamous meta-
plasia. The dominant tumor nodules of both cases
contained large, well-circumscribed but unencapsulated
aggregation of mature plasma cells and scattered centro-
cyte-like cells (CCL-cells). Both lesions contained a few
lymphoepithelial lesions. Moreover, immunohistochemical
study demonstrated that plasma cells and CCL-cells of
these two lesions contained monotypic intracytoplasmic
kappa light chain. Other small B-cell lymphomas, plas-
macytoma and plasmablastic lymphoma were excluded
using stains for CD5, CD10, CD23, CD43, CD56. Cyclin
D1, human herpes virus type-8.
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Introduction
Although the pathologic diagnosis of lymphoma tradi-
tionally depend on the major criteria of cellular
cytological atypia and monomorphism, marginal zone B-
cell lymphomas (MZBL) of mucosa associated lympho-
cytic tissue (MALT) type occasionally lack signiﬁcant
cytological atypia [1]. Moreover, polymorphous lymphoid
inﬁltrate of plasma cells, macrophages and centrocyte
like-cells (CCL-cells) is frequently found in MALT type
lymphomas [1].
In common with other sites where MALT type lym-
phomas arise, the thyroid gland is devoid of native
lymphoid tissue. Lymphoid tissue acquired in the course
of Hashimoto’s thyroiditis (HT) bears a close resemblance
to MALT. Histologically, HT is characterized by the
presence of B-cell follicles, inﬁltration of thyroid epithe-
lium by B-cells, and plasma cell differentiation.
Moreover, in comparison with other MALT type lym-
phomas, plasma cell differentiation is more prominent in
thyroid MALT type lymphoma. As a result, CCL-cells
were obscured by numerous mature plasma cells [1–3].
We present here two cases of incidental MALT type
lymphoma showing prominent plasma cell differentiation
associated with HT.
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Case 1
An 82-year-old Japanese male was admitted to our hospital
with a six-month history of painless left neck mass.
Physical examination demonstrated a nodule on the left
side of the thyroid gland. Abnormal laboratory test results
included an elevated thyroid-stimulating hormone (TSH)
level of 73 lIU/ml (normal\0.4) and a free thyroxine (T4)
concentration of 0.3 ng/dl (normal 0.7–1.5). There was no
other evidence of disease. Left lobectomy was performed.
The left lobe was nodular and ﬁrm. A white well demar-
cated nodule measuring 1 cm was present in the lower pole
of the left lobe (Fig. 1a). The patient remained free of
disease on examination two months later.
Case 2
A 78-year-old Japanese female was admitted to our hos-
pital with a painless right neck mass. Physical examination
demonstrated a nodule on the right side of the thyroid
Fig. 1 (a) Cut surface of the resected specimen. A white well
demarcated nodule measuring 1 cm was present in the lower left lobe
(arrow) case 1. (b) On low-power ﬁeld, the dominant nodule was
well-circumscribed but unencapsulated (arrow) against background of
sclerosis. HE 91.25 case 1. (c) On high-power ﬁeld, the nodule
demonstrated numerous mature plasma cells, a few CCL-cells (arrow)
and large transformed lymphocytes. Note a Dutcher body (arrow
head). HE 9100 case 1. (d) Numerous mature plasma cells and a few
CCL-cells (arrow) inﬁltrated the thyroid gland acini forming
lymphoepithelial lesions. Note a residual thyroid gland epithelium
(arrow head). HE 940 case 2. Immunohistochemical study demon-
strated that numerous neoplastic plasma cells and a portion of CCL-
cells (arrow) were kappa light chain positive (e) but lambda light
chain negative. Note a few polyclonal plasma cells in the back ground
(f) 940 case 2
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microsome test (96400). There was no other evidence of
disease. Right lobectomy was performed. The right lobe
was nodular and ﬁrm. A 1.5 cm white well demarcated
nodule was present in the lower pole of the lobe. The
patient remained free of disease on examination 18 months
later.
Materials and Methods
Both the clinical ﬁndings and parafﬁn blocks were avail-
able for both cases. The tissue specimens were ﬁxed in
formalin solution, routinely processed and embedded in
parafﬁn. For light microscopic examination, the sections
were stained with hematoxylin–eosin (HE).
Immunohistochemical studies were performed using the
Ventana automated (BenchMarkTM) stainer according to
the manufacturer’s instructions. The panel of antibodies
included human immunoglobulin light chains (kappa and
lambda) (Novocastra, Newcastle, UK), PS-1 (CD3; Im-
munotech, Marseille, France), 4C7 (CD5; Novocastra),
56C6 (CD10; Novocastra), L26 (CD20; Dako A/S, Glost-
rup, Denmark), 1B12 (CD 23; Novocastra), DFT-1 (CD43;
Dako), 1B16 (CD56; Novocastra), 5A4 (p80; Novocastra),
SP4 (Cyclin D1; Nichirei Co., Tokyo, Japan), 124 (bcl-2;
Dako), AE1/3 (cytokeratin; Dako) and 137B1 (human
herpes virus type-8 [HHV-8], Novocastra). Sections with
known reactivity for the antibodies assayed served as
positive controls and the sections treated with normal
rabbit- and mouse serum served as negative controls.
In situ hybridization (ISH) with Epstein–Barr virus
(EBV)-encoded small RNA (EBER) oligonucleotides was
performed to test for the presence of EBV small RNA in
formalin-ﬁxed parafﬁn-embedded sections using a Ventana
automated (BenchMarkTM) stainer.
Results
Both patients showed essentially similar histological and
immunohistochemical ﬁndings. Histological examination
demonstrated that both lesions exhibited HT including
lymphoplasmacytic inﬁltration with the formation of ger-
minal centers, destruction of the normal thyroid follicular
architecture, Hu ¨rthle cell changes, and squamous meta-
plasia. Focal ﬁbrosis was also noted. The dominant nodule
in both cases contained large, well-circumscribed but
unencapsulated aggregation of mature plasma cells against
a background of sclerosis (Fig. 1b). In case 1, a portion of
the mature plasma cells demonstrated intranuclear inclu-
sions (Dutcher body) (Fig. 1c). Scattered small-to-medium
lymphocytes and large lymphoid cells were also
intermingled with plasma cells. In both lesions, medium-
sized lymphocytes had round or slightly indented nuclei
with small conspicuous nucleoli and a moderate amount of
clear cytoplasm (centrocyte-like cells; CCL-cells)
(Fig. 1c). In the background, there were a few remnants of
destroyed thyroid follicles. Numerous mature plasma cells
and a few CCL-cells inﬁltrated the thyroid gland acini
forming lymphoepithelial lesions (LeLs) (Fig. 1d). How-
ever, both lesions contained only a few LeLs. A few
remnants of residual lymphoid follicles were also noted.
The majority of mature plasma cells and a portion of
CCL-cells in the main nodules showed intracytoplasmic
kappa light chain (Fig. 1e, f). However, the plasma cells
outside the main nodules showed a polytypic nature.
CCL-cells were also CD 20 positive. However, there
were no CD5, CD10, CD23, CD43, Cyclin D1, HHV-8
positive B-cells in either lesion. There were no CD56
positive plasma cells in either lesion. Other small B-cell
lymphomas, plasmacytoma and plasmablastic lymphoma
were excluded using stains for CD5, CD10, CD23, CD43,
CD56. Cyclin D1, HHV-8 [4]. CD23 immunostain dem-
onstrated a few residual follicular dendritic cell network
colonized by the neoplastic plasma cells and CCL-cells.
LeLs were also highlighted by cytokeratin immunostain-
ing. There were no Epstein–Barr virus (EBV)-encoded
small RNA (EBER) positive cells in any of the lesions on
in situ hybridization using a Ventana automated (Bench-
MarkTM) stainer.
The plasma cells outside the main nodules showed
polytypic nature.
Discussion
Hussung et al. [5] reported ﬁve cases of extramedullary
plasmacytoma that showed characteristic histological
ﬁndings of MZBL, including the presence of a marginal
zone distribution pattern, CCL-cells, reactive lymphoid
follicles with or without follicular colonization and LeL at
sites where epithelium was present. Based on these
observations, they suggested that a portion of extramed-
ullary plasmacytoma can be regarded as an extreme
plasmacytic differentiation of MZBCL [5]. In both lesions
reported here, numerous mature plasma cells and a few
CCL-cells contained monotypic intracytoplasmic kappa
light chain. Moreover, immunostain highlighted a few
LeLs and remnants of follicular dendritic cell network
colonized by the neoplastic plasma cells and CCL-cells. As
Hussung et al. [5] suggested, both of our cases would best
be classiﬁed as MZBCL of MALT type showing prominent
plasma cell differentiation.
The present two cases should be differentiated from
various benign and plasma cell lesions that affect thyroid
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plasma cell variant (plasma cell granuloma; PCG) appears
to be the most important lesion in the differential diagnosis.
[6–9]. PCG is a non-neoplastic proliferation of plasma cells
within a ﬁbrous stroma with unknown etiology. PCG of the
thyroid gland is very rare [7–9]. However, PCG of the
thyroid gland is occasionally associated with HT [7–9].
Histologically, there is a diffuse and focally nodular inﬁl-
tration of numerous mature plasma cells intermixed with
lymphocytes and surrounded by ﬁbrous tissue [7–9].
Moreover, squamous metaplasia with lymphoplasmacytic
inﬁltration somewhat resembling LeL in MALT type
lymphoma was noted. Overall histomorphological ﬁndings
of the present two cases were similar to those of PCG
associated with HT. However, immunohistochemical study
demonstrated the polytypic nature of plasma cells in PCG,
whereas plasma cells of both lesions reported here, dem-
onstrated monotypic intracytoplasmic kappa light chain
[7–9].
Thyroid gland involvement of multiple myeloma is
ruled out by laboratory and clinical examination [7].
Moreover, there were no CD56 positive plasma cells in any
of the lesions [10]. Extramedullary plasmacytoma is
another differential diagnostic problem. However, there
were no CD20 positive tumor cells in the extramedullary
plasmacytoma, whereas both lesions in this series con-
tained a few CD20 positive CCL-cells.
Previously, Hyjek and Isaacson [2] reported that anal-
ysis of thyroid glands from 236 cases of surgically treated
HT demonstrated ﬁve cases (2.1%) of incidental MALT
type lymphoma. We also found two cases (3.8%) of inci-
dental MALT type lymphoma showing prominent plasma
cell differentiation among 53 cases of surgically treated HT
treated by one of the authors (M. K) between 1982 and
2007. As Hyjek and Isaacson [2] indicated, given the
indolent nature of thyroid MALT type lymphoma, as
deﬁned by light chain restriction of the B-cells and
plasmacytic inﬁltrate arising in HT, it is conceivable that
the true incidence of thyroid MALT type lymphoma may
be much higher than recognized.
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